W28-26496-56965
5 vaccinations
5 coded responses
43 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 190 / PA
- Registered
- 2021-03-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
3AE-24781-64489
Child or adolescent in my care · Male · 2022-06-30
Timeline
-
2021-02-25
Dose 1 — Pfizer-BioNTech
-
2021-03-05
Registered in v-safe
- 2021-03-05
- 2021-03-11
-
2021-03-18
Dose 2 — Pfizer-BioNTech
- 2021-03-18
-
2021-03-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-20
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body achesAdult check-in
- 2021-03-22
-
2021-03-23
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains, Fatigue or tirednessAdult check-in
- 2021-03-24
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-04-29
- 2021-09-16
-
2021-10-01
Dose 3 — Pfizer-BioNTech
-
2021-10-01
Survey response — day 0, dose 3MedDRA: Pregnancy — Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-10-04
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Joint pains, Muscle or body achesAdult check-in
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-17
- 2021-10-22
- 2021-10-29
- 2021-11-07
- 2021-11-12
- 2021-12-31
-
2022-03-08
Dose 4 — Pfizer-BioNTech
- 2022-04-01
-
2022-09-08
Survey response — 6 months, dose 4MedDRA: Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend schoolFree text: Severe sore throat, congestion, but negative Covid testsMedDRA releases: 2024-11 · check-in free text available
-
2022-09-09
Dose 5 — Moderna
-
2022-09-10
Health check-in — days 1–6 daily, dose 5Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend schoolAdult check-in
-
2022-09-11
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-09-12
-
2022-09-13
Survey response — days 1–6 daily, dose 5MedDRA: Dyspepsia, Oropharyngeal pain — Feeling: Good · Site: Pain · HeadacheFree text: Heartburn, sore throatMedDRA releases: 2024-11 · check-in free text available
- 2022-09-16
- 2022-09-23
- 2022-09-30
- 2022-10-07
-
2022-10-14
Survey response — day 35, dose 5MedDRA: Dyspepsia, Gastrooesophageal reflux disease, Oropharyngeal pain — Feeling: FairFree text: Reflux is worse. Heart burn and sore throatMedDRA releases: 2024-11 · check-in free text available
- 2022-10-21
- 2022-12-09
-
2023-03-10
Survey response — 6 months, dose 5MedDRA: Discharge, Dysphonia, Nasopharyngitis, Oropharyngeal pain, SARS-CoV-2 test negative — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-25 | Pfizer-BioNTech | |
| 2 | 2021-03-18 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
| 4 | 2022-03-08 | Pfizer-BioNTech | No |
| 5 | 2022-09-09 | Moderna | No |
Free text
Release 9 — day 0, dose 3
Systemic reaction (other): Pregnancy
Release 12 — 6 months, dose 4
Symptoms: Severe sore throat, congestion, but negative Covid tests
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): Heartburn, sore throat
Release 12 — day 35, dose 5
Symptoms: Reflux is worse. Heart burn and sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Discharge | · | · | ✓ |
| SD | Dyspepsia | · | · | ✓ |
| SD | Dysphonia | · | · | ✓ |
| SD | Gastrooesophageal reflux disease | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Dyspepsia | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release